Below you'll find a list of all posts that have been categorized as “Lab Updates”
EKG Labs is now the proud owner of an Agilent Triple Quadrupole GC/MS. This instrument is a cutting-edge tool for identifying, characterizing, and quantifying volatile and semi-volatile compounds even in challenging matrices. While EKG already has multiple GC systems, this new instrument provides expanded analytical capabilities. Though primarily intended for our …
2023 is kicking off in high gear at EKG Labs. Some of our plans for the year include: We are also looking forward to speaking and exhibiting at a number of pharmaceutical and medical device conferences across the United States. In the first half of the year, we will be attending the …
EKG Labs is now the proud owner of an Agilent Ultra High Performance Liquid Chromatograph (UHPLC) with Quadrupole Time of Flight Mass Spectrometry Detection (q-ToF MS). This instrument is a cutting-edge tool for profiling, identifying, characterizing, and quantifying non-volatile and semi-volatile compounds and biomolecules even in challenging matrices. While EKG …
In case you haven’t heard…EKG Life Science Solutions (EKG Labs) has been officially acquired by Infinity Laboratories! Infinity Laboratories is a national chemical and microbiological testing laboratory servicing the pharmaceutical, biotechnology, and medical device industries. This acquisition brings us into a network of labs across the United States with a …
Near the end of 2021, we sent out a survey to our clients and were overwhelmed by the enthusiasm of the responses we received. 100% of respondents said they felt EKG was able to partner with them on a closer level than a large analytical testing provider may have been. 100% of …
EKG Labs has moved! We are thrilled to announce that we have transferred all operations from our former incubator location into a space of our very own within one of St. Louis’s most popular areas for business and scientific industry. The complete facility is over 10,000 square feet, including dramatically …
EKG Labs is thrilled to share with you that we have been ranked as a top medical device testing company by MedTech Outlook. We will be featured in the upcoming MedTech Outlook magazine as a Top 10 Medical Device Testing and Certification Company—2020. You can access our article “Medical Device …
To our valued Customers and Partners, We want to reach out to all of our customers to provide an update on EKG Labs’s response to the COVID-19 virus pandemic. The first item to note is that EKG Labs has not been directly impacted by the COVID-19 virus, and we are …
At the end of 2019, we sent out a survey to our clients and were overwhelmed by the enthusiasm of the responses we received. Here’s what our current clients had to say. 100% of respondents said they felt EKG was able to partner with them on a closer level than …
EKG Labs is excited for another year of traveling across the country and connecting with the broader pharmaceutical and medical devices communities. We currently have six conferences on our calendars (see table below for details). The topics vary from changing industry standards in extractable and leachable testing, to the challenges …
Returning from Thanksgiving break and turkey feasts, EKG Labs has been reflecting on the many things we are thankful for in 2018. Building up our family of scientists by expanding the number of analysts working in our lab Installing a brand new UHPLC with a Time-of-Flight MS in our lab …
Over the past couple years, EKG Labs has been excited about new opportunities for community outreach. In particular, EKG has been traveling to elementary schools across St. Louis, both private and public, to bring chemistry to the classroom. Some of these events have been focused on leading a small classroom …
Throughout 2018 EKG Labs has been traveling the country, attending a wide variety of pharmaceutical and medical device conferences. Dr. Allen Kesselring, Chief Science Officer at EKG Labs, attended Smithers Rapra’s E&L USA 2018 and presented on the evolution and challenges of USP <661.1> and <661.2> at PharmaEd’s Extractables, Leachables …
EKG Labs is excited to announce that we will be attending E&L USA 2018 from May 7-9 in Bethesda, Maryland. As a leader in the pharmaceutical and medical device testing field, EKG continues to attend, present, and exhibit at key industry conferences throughout the year. Notably, EKG will be returning …
As of March 2018, EKG Labs is now the proud owner of an Agilent Ultra High Performance Liquid Chromatograph (UHPLC) with Accurate-Mass Time of Flight Mass Spectrometry Detection (ToF MS). This instrument is a cutting-edge tool for profiling, identifying, characterizing, and quantifying low molecular-weight compounds and biomolecules even in challenging …
It’s convention season, and EKG Labs is excited to announce that we will be attending two conferences in California within the next few weeks. Every year we make an effort to attend crucial conferences in our field. It is very important to our lab that we continue to learn from …
St. Louis, MO – April 10, 2017 – EKG Life Science Services, LLC (EKG Labs), an analytical services laboratory supporting medical device and pharmaceutical development, is pleased to announce the company has updated its corporate identity including logo and website. The new updates modernize the brand’s image and will help …
EKG Labs Expands Analytical Laboratory for Medical Device and Pharmaceutical Services St. Louis, MO – March 2, 2017 – EKG Life Science Services, LLC (EKG Labs), an analytical services laboratory supporting medical device and pharmaceutical development, announces the expansion of its analytical laboratories. Located in the Innovative Technology Enterprises (ITE) …
After wrapping up 2015 with a successful Drug Enforcement Administration (DEA) registration; the first half of 2016 has provided new employees; conference invitations to present as industry experts; and a recently completed flawless FDA inspection. 2016 has been the biggest year yet for EKG.
EKG Life Science Solutions, LLC Announces Accreditation as Women-Owned Business Enterprise (WBE) St. Louis, MO— 12/31/14 — Today, EKG Life Science Solutions, LLC announced being certified as a Women-Owned Business Enterprise (WBE) by the state of Missouri. The laboratory was founded and is owned by Katie Grayson, Jennifer Eagan, and …
EKG Life Science Solutions Announces Acquisition of State of the Art Instrumentation Ion Trap LC/MS, GC with FID and TCD, and FT-IR St. Louis, MO— 11/26/14 — Today, EKG Life Science Solutions announced the addition of a High Pressure Liquid Chromatograph with Ion Trap Mass Spectrometry Detection (LC/MS), a Gas …
EKG Life Science Solutions recognized in FDA’s Generic Drug User Fee Amendments (GDUFA) self-identification process.
St. Louis Startup Challenge publishes YouTube channel with semi-finalist videos produced by KETC Channel 9.
